JMIR Cardio
Cardiovascular medicine with focus on electronic, mobile, and digital health approaches in cardiology and for cardiovascular health
Editor-in-Chief:
Andrew J. Coristine, PhD, Affiliate Faculty, Department of Medicine (Division of Cardiology), McGill University (Canada); Scientific Editor, JMIR Publications (Canada)
Impact Factor 2.2 CiteScore 4.3
Recent Articles

Remote patient monitoring (RPM) has emerged as an effective strategy for controlling hypertension by enabling patients to collect and transmit blood pressure (BP) data outside the clinic and supporting proactive care team interventions. While its benefits for hypertension management are well established, less is known about its effectiveness for patients with multiple chronic conditions (MCC), who experience higher morbidity, mortality, and costs.

Telemedicine enables the provision of health services at a distance using information and communication technologies and includes different types of services: telemonitoring, remote control, virtual visit or televisit, tele referral, teleassistance, medical teleconsultation, health professionals’ teleconsultation and tele rehabilitation. Continuous monitoring, early care, and greater therapeutic adherence could be benefits of telemedicine in the management of cardiovascular diseases. There are not many studies in the literature investigating the use of telemedicine in cardiology in Italy.

Effective hypertension management, particularly through self-care strategies, remains a significant public health challenge. Despite widespread awareness, only approximately 1 in 5 adults achieve adequate blood pressure (BP) control. There is a growing need for scalable digital health interventions that enhance awareness, support behavioral change, and improve clinical outcomes. However, real-world evidence evaluating the impact of such interventions on BP levels and their underlying mechanisms is limited.

The management of heart failure (HF) requires complex, data-driven decision-making. Although electronic health record (EHR) systems and clinical decision support (CDS) tools can streamline access to essential clinical information, it remains unclear which EHR elements and tools cardiologists and general medicine physicians prioritize when caring for HF patients.


Remote care technology has been used to bridge the gap between healthcare in a clinical setting and in the community, all the more essential post-covid. Patients with chronic conditions may benefit from interventions that could provide more continuous and frequent monitoring of their disease process and support self-management. A common barrier however is the lack of engagement with technological interventions or devices that provide care remotely, which could lead to loss of resources invested and reduced quality of care.

Emergency Department (ED) crowding is often attributed to a slow hospitalization process, leading to reduced quality of care. Predicting early disposition with cardiac-presenting patients is challenging: most are ultimately discharged, yet those with a cardiac etiology frequently require hospital admission. Existing scores rely on single-time-point data and often underperform when patient risk evolves during the visit.


Wearable devices offer a promising solution for remotely monitoring heart rate (HR) during home-based cardiac rehabilitation. However, evidence regarding their accuracy across varying exercise intensities and patient profiles remains limited, particularly in populations with cardiovascular disease (CVD), such as those with heart failure (HF).

Exercise capacity and lifestyle have proven to be important prognostic factors for cardiovascular patients. Both can be ameliorated through different preventive interventions. Cardiac rehabilitation (CR) and remote patient monitoring (RPM) have proven to reduce cardiac events and cardiovascular mortality. One of the most important goals of CR and RPM is improving physical fitness and monitoring of cardiovascular parameters which could predict cardiac deterioration. In order to monitor cardiac patients successfully, reliable and non-obtrusive devices to assess physical activity (PA) and cardiovascular parameters need to be available.

Efforts to improve diversity in clinical trials often prioritize recruitment based on broad demographic factors. This approach may overlook the influence of community context and health-related social needs on health behaviors, including sodium intake, a key modifiable risk factor for hypertension and cardiovascular disease.
Preprints Open for Peer-Review
Open Peer Review Period:
-
Open Peer Review Period:
-












